专利检索 ap:("ALNYLAM PHARMACEUTICALS, INC.") AND inv:"HO-CHOU TU" 第 1 页

1.

发明申请
COMPOSITIONS AND METHODS FOR SILENCING DNAJB1-PRKACA FUSION GENE EXPRESSION 有权

公开(公告)号：US20230040920A1

公开(公告)日：2023-02-09

申请号：US17773508

申请日：2020-10-30

申请人： ALNYLAM PHARMACEUTICALS, INC.

发明人： LEILA NOETZLI , HO-CHOU TU , PATRICK HASLETT , JAMES MCININCH

IPC分类号： C12N15/113 , A61P35/00

摘要： The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the DNAJB 1-PRKAC A fusion gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of DNAJB 1-PRKAC A fusion.

2.

发明申请
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE 有权

公开(公告)号：US20220290152A1

公开(公告)日：2022-09-15

申请号：US17639881

申请日：2020-09-02

申请人： ALNYLAM PHARMACEUTICALS, INC.

发明人： HO-CHOU TU , JAMES MCININCH

IPC分类号： C12N15/113 , A61K31/713

摘要： The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the LECT2 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of LECT2.